Please ensure Javascript is enabled for purposes of website accessibility

2 Smart Ways for Robinhood Investors to Play the Cannabis Craze

By Sean Williams - Jun 15, 2021 at 6:36AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A major pitfall in Robinhood's platform makes it difficult to buy high-quality pot stocks. Here are two genius workarounds to the problem.

Though all eyes have been on the tech sector for more than a year, it's cannabis that might offer the greatest growth opportunity for investors through the end of the decade.

Although estimates vary wildly -- as we'd expect from an industry that's operated illicitly for decades -- sustainable double-digit growth is the expectation. New Frontier Data has forecasted 21% average annual sales growth between 2019 and 2025 in the U.S., which would lead to more than $41 billion in yearly revenue by mid-decade. Meanwhile, cannabis-focused research firm BDSA expects Canadian pot sales to more than double from $2.6 billion to $6.4 billion between 2020 and 2026.

This rapid growth, coupled with the general favorability of cannabis by the younger generation, is precisely why millennials on online investing app Robinhood have piled into marijuana stocks.

A handful of dried cannabis buds set atop a messy pile of cash bills.

Image source: Getty Images.

Robinhood takes the buzz out of investing in cannabis

Unfortunately, Robinhood investors are faced with a mammoth pitfall inherent in the platform: over-the-counter stocks are off-limits. Robinhood's online investing platform offers free commissions, but investors are only allowed to purchase stocks that are listed on the major U.S. exchanges.

One of the odd quirks about investing in marijuana is that neither the New York Stock Exchange (NYSE) nor Nasdaq will allow companies that directly deal with the cannabis plant in the U.S. to list their shares. That's because marijuana is still an illicit substance at the federal level, even though close to three-quarters of all U.S. states have given marijuana the green light in some capacity. This means direct players in the most lucrative cannabis market in the world are relegated to the over-the-counter exchange. In other words, Robinhood investors can't buy them.

By comparison, Canadian pot stocks are allowed to list their shares on the NYSE and Nasdaq, with the caveat being they stay out of the U.S. marijuana industry as long as it remains illegal at the federal level. The problem is that the Canadian weed industry is wrought with regulatory and supply issues, leaving Robinhood investors to choose between poor-performing Canadian pot stocks and avoiding the industry altogether.

But there's good news. There are two smart ways Robinhood investors can still participate in the green rush without having the leave the platform.

Cannabis plants placed in a metal basket.

A basket of U.S. cannabis stocks could have investors seeing green. Image source: Getty Images.

Buy a U.S.-focused marijuana ETF

The absolute smartest workaround to being unable to invest in U.S. multistate operators (MSO) on Robinhood is to buy the exchange-traded fund (ETF) focused exclusively on U.S. marijuana stocks: AdvisorShares Pure U.S. Cannabis ETF (MSOS 3.85%).

The AdvisorShares Pure U.S. Cannabis ETF currently has more than $1 billion in net assets and holds stakes in 31 companies. The vast majority of the funds' invested holdings (almost 86%) are devoted to MSOs -- i.e., companies that control the cultivation, processing, and retail sale of pot products in the United States. MSOs happen to be the fastest-growing group of companies within the U.S. weed industry. 

For example, the largest holding in the fund, Curaleaf (CURLF 3.02%), accounts for 12.1% of current portfolio weighting. As of the beginning of June, Curaleaf had 106 operating dispensaries, as well as a retail, cultivation, or processing presence in 23 states. Following its acquisition of top-notch pot brand Select and privately held MSO Grassroots last year, Curaleaf is on track to be the first pot stock to hit $1 billion in sales. If Wall Street's forecast is correct, it could be pushing above $3 billion in annual revenue by 2024. 

You'll also gain access to the likes of Trulieve Cannabis (TCNNF 2.03%), the funds' third-largest holding. Trulieve recently reported its 13th consecutive quarterly profit. The company's success is a function of its laser focus on medical marijuana-legal Florida. Out of 88 operating dispensaries, 82 are located in the Sunshine State. Saturating Florida has helped raise brand awareness and keep Trulieve's marketing costs down. With the buyout of Harvest Health & Recreation pending, Trulieve will soon be rivaling Curaleaf in size.

An indoor commercial cannabis cultivation facility.

Image source: Getty Images.

Stick with high-performance ancillary pot stocks

If marijuana ETFs aren't your thing, Robinhood investors have one other smart option at their disposal: ancillary U.S. pot stocks. Ancillary cannabis businesses don't come into direct contact with the plant, but are nevertheless instrumental to the growth of the weed industry.

A perfect example of a successful ancillary marijuana stock is Innovative Industrial Properties (IIPR -1.07%). Innovative Industrial, or IIP for short, is a cannabis-focused real estate investment trust (REIT). It acquires medical marijuana cultivation and processing assets in the U.S. with the intent of leasing these properties out for long periods of time.

As of the beginning of June, it owned 72 properties spanning 6.6 million rentable square feet in 18 states. All of IIP's properties are fully leased out, with a weighted-average lease length of 16.8 years. It'll probably take less than half this time for Innovative Industrial Properties to completely recoup the $1.6 billion it's invested.

What's more, IIP's sale-leaseback program has been popular among MSOs. With cannabis banking reform stalled in Congress, MSOs have turned to IIP to raise capital. Under its sale-leaseback agreements, IIP buys cultivation or processing facilities for cash and immediately leases the property back to the seller. It's a highly profitable and predictable program for the company.

A commercial indoor hydroponic cannabis farm.

Image source: Getty Images.

Another ancillary stock with plenty of upside potential is GrowGeneration (GRWG -3.97%). GrowGeneration operates a chain of 55 hydroponic and organic garden centers in a dozen U.S. states. These stores sell everything from hydroponic equipment (growing plants in a nutrient-rich water solvent) to soil, lighting, nutrients, and pest solutions. In short, GrowGen aims to help cultivators maximize yield and minimize pests.

Although GrowGeneration won't be able to grow by a triple-digit percentage every year, its management team hasn't been shy about using acquisitions to expand its reach into new markets. In particular, the company now has 20 stores in California, the largest marijuana market in the world. 

If Robinhood investors want to take advantage of the cannabis craze, they should ditch the underperforming Canadian pot stocks and consider either ancillary weed stocks or the aforementioned AdvisorShares Pure U.S. Cannabis ETF.

Sean Williams has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends GrowGeneration Corp, Innovative Industrial Properties, and Trulieve Cannabis Corp. The Motley Fool recommends Nasdaq. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Innovative Industrial Properties Stock Quote
Innovative Industrial Properties
IIPR
$101.68 (-1.07%) $-1.10
Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
CURLF
$5.93 (3.02%) $0.17
Trulieve Cannabis Stock Quote
Trulieve Cannabis
TCNNF
$13.07 (2.03%) $0.26
GrowGeneration Corp. Stock Quote
GrowGeneration Corp.
GRWG
$5.32 (-3.97%) $0.22
AdvisorShares Trust - AdvisorShares Pure US Cannabis ETF Stock Quote
AdvisorShares Trust - AdvisorShares Pure US Cannabis ETF
MSOS
$12.15 (3.85%) $0.45

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
394%
 
S&P 500 Returns
127%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.